Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;27(4):57-63.
doi: 10.1007/s11916-023-01101-w. Epub 2023 Mar 10.

Medical Cannabis for Chronic Nonmalignant Pain Management

Affiliations
Review

Medical Cannabis for Chronic Nonmalignant Pain Management

Maha Hameed et al. Curr Pain Headache Rep. 2023 Apr.

Abstract

Purpose of review: Cannabis has been used since ancient times for medical and recreational research. This review article will document the validity of how medical cannabis can be utilized for chronic nonmalignant pain management.

Recent findings: Current cannabis research has shown that medical cannabis is indicated for symptom management for many conditions not limited to cancer, chronic pain, headaches, migraines, and psychological disorders (anxiety and post-traumatic stress disorder). Δ9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are active ingredients in cannabis that modulate a patient's symptoms. These compounds work to decrease nociception and symptom frequency via the endocannabinoid system. Research regarding pain management is limited within the USA as the Drug Enforcement Agency (DEA) classifies it as a schedule one drug. Few studies have found a limited relationship between chronic pain and medical cannabis use. A total of 77 articles were selected after a thorough screening process using PubMed and Google Scholar. This paper demonstrates that medical cannabis use provides adequate pain management. Patients suffering from chronic nonmalignant pain may benefit from medical cannabis due to its convenience and efficacy.

Keywords: Cannabis; Chronic nonmalignant pain; Medical marijuana; Opioids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Zelaya CE, Dahlhamer JM, Lucas JW, Connor EM. Chronic pain and high-impact chronic pain among U.S. adults, 2019. NCHS Data Brief. 2020 Nov;(390):1–8. - PubMed
    1. World Health Organization. Opioid overdose [Internet]. 2021 [cited 2022 May 12]. Available from: https://www.who.int/news-room/fact-sheets/detail/opioid-overdose
    1. Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, et al. A selective review of medical cannabis in cancer pain management. Ann Palliat Med. 2017;6(Suppl 2):S215–S222. doi: 10.21037/apm.2017.08.05. - DOI - PubMed
    1. Rein JL. The nephrologist’s guide to cannabis and cannabinoids. Curr Opin Nephrol Hypertens. 2020;29(2):248–257. doi: 10.1097/MNH.0000000000000590. - DOI - PMC - PubMed
    1. Carr D, Schatman M. Cannabis for chronic pain: not ready for prime time. Am J Public Health. 2019;109(1):50–51. doi: 10.2105/AJPH.2018.304593. - DOI - PMC - PubMed